Efficacy for Acute Pain Alleviation of 50 mg Diclofenac 1 Hour Prior to Endometrial Sampling in Cases of Abnormal Uterine Bleeding
35 Years
N/A
Female
Abnormal Uterine Bleeding Unrelated to Menstrual Cycle
Trial Information
Efficacy for Acute Pain Alleviation of 50 mg Diclofenac 1 Hour Prior to Endometrial Sampling in Cases of Abnormal Uterine Bleeding
Inclusion Criteria:
- Thai women at the age over 35 years old
- Presenting with abnormal uterine bleeding and have a plan of performing fractional
curettage
Exclusion Criteria:
- uterine anomalies
- pregnancy
- Pelvic inflammatory disease
- Uncontrolled medical conditions
- Known cases of gynecological diseases such as gynecological malignancy, abnormal pap
smear
- NSAIDs allergy
- contraindicate to NSAIDs use
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Treatment
Outcome Measure:
Effectiveness of Diclofenac Potassium for additional acute pain control in patient undergoing fractional curettage under paracervical block due to abnormal uterine bleeding
Outcome Description:
Effectiveness of oral 50 mg Diclofenac Potassium was measured by pain score using visual dialogue scale during operation and 30, 60, 90 and 120 minutes after procedure.
Outcome Time Frame:
1 Year
Safety Issue:
No
Authority:
Thailand: Ethical Committee
Study ID:
SIOGMVA001
NCT ID:
NCT01762306
Start Date:
November 2012
Completion Date:
June 2013
Related Keywords:
- Abnormal Uterine Bleeding Unrelated to Menstrual Cycle
- Hemorrhage
- Metrorrhagia
- Uterine Hemorrhage
- Adenoma
Name | Location |
|---|
